Icosavax Financials

Based on the key measurements obtained from Icosavax's financial statements, Icosavax is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.
  
Understanding current and past Icosavax Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Icosavax's financial statements are interrelated, with each one affecting the others. For example, an increase in Icosavax's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Icosavax's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Icosavax. Check Icosavax's Beneish M Score to see the likelihood of Icosavax's management manipulating its earnings.

Icosavax Stock Summary

Icosavax competes with Terns Pharmaceuticals, Amylyx Pharmaceuticals, Acumen Pharmaceuticals, Inozyme Pharma, and X4 Pharmaceuticals. Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company was incorporated in 2017 and is headquartered in Seattle, Washington. Icosavax operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS45114M1099
Business Address1930 Boren Avenue,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websiteicosavax.com
Phone206 737 0085
CurrencyUSD - US Dollar

Icosavax Key Financial Ratios

Icosavax Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Icosavax's current stock value. Our valuation model uses many indicators to compare Icosavax value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Icosavax competition to find correlations between indicators driving Icosavax's intrinsic value. More Info.
Icosavax is rated below average in return on equity category among its peers. It is rated fifth overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Icosavax's earnings, one of the primary drivers of an investment's value.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in Icosavax Stock

If you are still planning to invest in Icosavax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Icosavax's history and understand the potential risks before investing.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Fundamental Analysis
View fundamental data based on most recent published financial statements
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Commodity Directory
Find actively traded commodities issued by global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges